§ BIOTECHNOLOGY
USD · Biotechnology

IOVA

IOVANCE BIOTHERAPEUTICS INC
USDSector · BiotechnologyBeta · 0.64
LAST
n/a
n/aPREV CLOSE · n/a
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX

§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY

13F FLOW
180 increased/new, 66 decreased/exited (13F)
AC 13F Analysis

§ 04 · FUNDAMENTALS · THE BOOKS

P/B1.55EPS (TTM)-1.12
§ 05 · WHO OWNS IT
Top institutional holders
All holders →
FundShares% portΔ Q/Q
BlackRock, Inc.31.1M0.0%+5%
MHR FUND MANAGEMENT LLC29.0M7.4%±0%
State Street17.4M0.0%−13%
VANGUARD CAPITAL MANAGEMENT LLC16.6Mn/an/a
TWO SIGMA INVESTMENTS, LP13.7M0.0%+211%
VANGUARD PORTFOLIO MANAGEMENT LLC11.7Mn/an/a
◇ AC INTELLIGENCE

Top institutional owners for IOVA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.

§ 06 · WHO OWNS IT · BY STRATEGY

OTHER81.7% · 0 holders
OTHER9.8% · 206 holders
DEALER / BANK3.3% · 26 holders
PASSIVE / INDEX2.8% · 10 holders
TACTICAL / MACRO0.9% · 4 holders
QUALITY / COMPOUNDER0.5% · 16 holders
ACTIVIST0.5% · 1 holder
SYSTEMATIC / QUANT0.4% · 7 holders
INCOME / DEFENSIVE0.1% · 15 holders
GROWTH / MOMENTUM0.0% · 1 holder
DEEP VALUE0.0% · 1 holder
◇ AC INTELLIGENCE

Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.

§ 07 · INSIDER ACTIVITY · LAST 180 DAYS

NO INSIDER FILINGS
◇ AC INTELLIGENCE

No Form 4 filings on record for IOVA in the last 180 days.

§ 08 · COVERAGE · OUR RECENT NOTES

No notes mention IOVA yet.